Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Ended earlyNCT01861054
What this trial is testing

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Who this might be right for
Breast Cancer
Dompé Farmaceutici S.p.A 20
Not applicableStudy completedNCT01930981
What this trial is testing

Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Who this might be right for
Hematologic MalignanciesOther Diagnoses, Comorbidities, and Complications
Fred Hutchinson Cancer Center 252
Not applicableStudy completedNCT07379528
What this trial is testing

Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome

Who this might be right for
Acute Myeloid Leukaemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 70
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Testing effectiveness (Phase 2)UnknownNCT04622956
What this trial is testing

GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide

Who this might be right for
Graft Vs Host DiseaseHematopoietic Neoplasm
University of Sao Paulo General Hospital 47
Not applicableActive Not RecruitingNCT05709912
What this trial is testing

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Who this might be right for
Bone Marrow Transplant ComplicationsHematologic Malignancy
Massachusetts General Hospital 120
Not applicableStudy completedNCT00997529
What this trial is testing

Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Beth Israel Deaconess Medical Center 14
Testing effectiveness (Phase 2)Study completedNCT01058239
What this trial is testing

Bortezomib Plus Rituximab for EBV+ PTLD

Who this might be right for
Post-transplant Lymphoproliferative DiseaseSolid Organ TransplantStem Cell Transplant (Bone Marrow Transplant)+1 more
Massachusetts General Hospital 7
Not applicableStudy completedNCT00511537
What this trial is testing

Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders

Who this might be right for
CMLALLAML+3 more
University of California, San Francisco 30
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Large-scale testing (Phase 3)Study completedNCT00430365
What this trial is testing

Maintenance Therapy Using Lenalidomide in Myeloma

Who this might be right for
Myeloma
University Hospital, Toulouse 614
Large-scale testing (Phase 3)Study completedNCT00003972
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
Fred Hutchinson Cancer Center 280
Early research (Phase 1)Study completedNCT01158300
What this trial is testing

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT01225419
What this trial is testing

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

Who this might be right for
Children Cancer, Solid Tumor
University Hospital, Clermont-Ferrand 5
Not applicableLooking for participantsNCT06111612
What this trial is testing

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06673459
What this trial is testing

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Who this might be right for
T-Cell Lymphocytic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONTotal Body Irradiation+1 more
The First Affiliated Hospital of Soochow University 430
Testing effectiveness (Phase 2)UnknownNCT03292263
What this trial is testing

ASCT With Nivolumab in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
St. Petersburg State Pavlov Medical University 30
Next Page